The trial of the drugs, already approved for malaria, cancer and autoimmune diseases, will involve researchers at more than 600 hospitals in 52 countries.
Published: August 11, 2021 at 06:45PM
from NYT Health https://ift.tt/37zhTyX
The trial of the drugs, already approved for malaria, cancer and autoimmune diseases, will involve researchers at more than 600 hospitals in 52 countries.
Published: August 11, 2021 at 06:45PM
from NYT Health https://ift.tt/37zhTyX